Life ScienceCompany
Pharmaceutical Strategies Group has acquired 1 company. It has also divested 2 assets.
It’s largest disclosed sale occurred in 2020, when it sold Pharmaceutical Strategies Group - 340B Software-Enabled Service Business to Omnicell for $225M. Pharmaceutical Strategies Group has acquired in 1 US state. The Company’s most targeted sectors include healthcare services (100%).
Join Mergr and gain access to Pharmaceutical Strategies Group’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity1
- M&A Sell Activity2
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 2
- M&A Advisors 2